In contrast, the prevalence of AF in DMD patients is relatively low, even after they develop overt cardiomyopathy,8 suggesting that absence of dystrophin may not result in miR-31 up-regulation or a significant reduction in NO availability in the atrial myocardium. The gene discussed is DMD; the disease is atrial fibrillation.